28 related articles for article (PubMed ID: 38514346)
1. Risk Factors for Thyroid Dysfunction in Pregnancy: An Individual Participant Data Meta-Analysis.
Osinga JAJ; Liu Y; Männistö T; Vafeiadi M; Tao FB; Vaidya B; Vrijkotte TGM; Mosso L; Bassols J; López-Bermejo A; Boucai L; Aminorroaya A; Feldt-Rasmussen U; Hisada A; Yoshinaga J; Broeren MAC; Itoh S; Kishi R; Ashoor G; Chen L; Veltri F; Lu X; Taylor PN; Brown SJ; Chatzi L; Popova PV; Grineva EN; Ghafoor F; Pirzada A; Kianpour M; Oken E; Suvanto E; Hattersley A; Rebagliato M; Riaño-Galán I; Irizar A; Vrijheid M; Delgado-Saborit JM; Fernández-Somoano A; Santa-Marina L; Boelaert K; Brenta G; Dhillon-Smith R; Dosiou C; Eaton JL; Guan H; Lee SY; Maraka S; Morris-Wiseman LF; Nguyen CT; Shan Z; Guxens M; Pop VJM; Walsh JP; Nicolaides KH; D'Alton ME; Visser WE; Carty DM; Delles C; Nelson SM; Alexander EK; Chaker L; Palomaki GE; Peeters RP; Bliddal S; Huang K; Poppe KG; Pearce EN; Derakhshan A; Korevaar TIM
Thyroid; 2024 May; 34(5):646-658. PubMed ID: 38546971
[No Abstract] [Full Text] [Related]
2. Clinical biomarkers for thyroid immune-related adverse events in patients with stage III and IV gastrointestinal tumors.
Xing N; Liu J; Hou L; Zhao Y; Ma H; Wang F; Guo Z
Front Immunol; 2024; 15():1381061. PubMed ID: 38774877
[TBL] [Abstract][Full Text] [Related]
3. Safety and clinical efficacy of immune checkpoint inhibitors in advanced gastric cancer in the real world.
Hao W; Liu W; Chang R; Yang M; Xin K; Liu J; Wang Y; Ren M; Xie J; Yang Y
J Cancer Res Clin Oncol; 2024 Apr; 150(4):180. PubMed ID: 38587528
[TBL] [Abstract][Full Text] [Related]
4. Risk of Thyroid Dysfunction in PD-1 Blockade Is Stratified by the Pattern of TgAb and TPOAb Positivity at Baseline.
Zhou X; Iwama S; Kobayashi T; Ando M; Arima H
J Clin Endocrinol Metab; 2023 Sep; 108(10):e1056-e1062. PubMed ID: 37084392
[TBL] [Abstract][Full Text] [Related]
5. Association of Antithyroid Antibodies in Checkpoint Inhibitor-Associated Thyroid Immune-Related Adverse Events.
Muir CA; Wood CCG; Clifton-Bligh RJ; Long GV; Scolyer RA; Carlino MS; Menzies AM; Tsang VHM
J Clin Endocrinol Metab; 2022 Apr; 107(5):e1843-e1849. PubMed ID: 35104870
[TBL] [Abstract][Full Text] [Related]
6. Changes in TgAb and TPOAb titers are greater in thyrotoxicosis than isolated hypothyroidism induced by PD-1 blockade.
Yamagami A; Iwama S; Kobayashi T; Zhou X; Yasuda Y; Okuji T; Ito M; Izuchi T; Ando M; Onoue T; Miyata T; Sugiyama M; Hagiwara D; Suga H; Banno R; Arima H
Endocr J; 2024 May; 71(5):515-526. PubMed ID: 38599854
[TBL] [Abstract][Full Text] [Related]
7. Thyroid dysfunction after immune checkpoint inhibitor treatment in a single-center Chinese cohort: a retrospective study.
Wu L; Xu Y; Wang X; Cheng X; Zhang Y; Wang Y; Fan X; Zhao H; Liu H; Chai X; Zhang L; Wang M; Li N; Pan H; Lian X
Endocrine; 2023 Jul; 81(1):123-133. PubMed ID: 36867366
[TBL] [Abstract][Full Text] [Related]
8. Higher baseline TSH levels predict early hypothyroidism during cancer immunotherapy.
Luongo C; Morra R; Gambale C; Porcelli T; Sessa F; Matano E; Damiano V; Klain M; Schlumberger M; Salvatore D
J Endocrinol Invest; 2021 Sep; 44(9):1927-1933. PubMed ID: 33576954
[TBL] [Abstract][Full Text] [Related]
9. [The association between baseline TPOAb and/or TgAb positivity and thyroid immune-related adverse events in patients with malignancies following treatment with immune checkpoint inhibitors].
Gao Y; Ye T; Wu LG; Xu Y; Wang X; Cheng XQ; Zhang YL; Wang YY; Fan XR; Zhao HT; Liu H; Chai XF; Zhang L; Wang MZ; Li NS; Lian XL
Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(12):963-969. PubMed ID: 38514346
[No Abstract] [Full Text] [Related]
10. Clinical Characteristics, Management, and Potential Biomarkers of Endocrine Dysfunction Induced by Immune Checkpoint Inhibitors.
Iwama S; Kobayashi T; Arima H
Endocrinol Metab (Seoul); 2021 Apr; 36(2):312-321. PubMed ID: 33934588
[TBL] [Abstract][Full Text] [Related]
11. [Antibodies against thyroid gland peroxidase and thyroglobulin in various thyroid diseases].
Földes I; Lévay A
Orv Hetil; 1994 Jul; 135(29):1579-84. PubMed ID: 8058301
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
